Dr. Wheatley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5601 Fishers Lane
Rockville, MD 20850Phone+1 240-627-3573- Is this information wrong?
Education & Training
University of Pennsylvania Health SystemFellowship, Allergy and Immunology, 1990 - 1994
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1987 - 1989
Rutgers Health/Robert Wood Johnson Medical SchoolInternship, Internal Medicine, 1986 - 1987
Loyola University Chicago Stritch School of MedicineClass of 1986
Certifications & Licensure
OR State Medical License 1999 - 2025
Publications & Presentations
PubMed
- 2 citationsOmalizumab for the Treatment of Multiple Food Allergies.Robert A Wood, Alkis Togias, Scott H Sicherer, Wayne G Shreffler, Edwin H Kim, Stacie M Jones, Donald Y M Leung, Brian P Vickery, J Andrew Bird, Jonathan M Spergel, Ah...> ;The New England Journal of Medicine. 2024 Mar 7
- Analytical challenges in omics research on asthma and allergy: A National Institute of Allergy and Infectious Diseases workshop.Supinda Bunyavanich, Patrice M Becker, Matthew C Altman, Jessica Lasky-Su, Carole Ober, Karsten Zengler, Evgeny Berdyshev, Richard Bonneau, Talal Chatila, Nilanjan Cha...> ;The Journal of Allergy and Clinical Immunology. 2024 Apr 1
- 2 citationsDeveloping a Prediction Model for Determination of Peanut Allergy Status in the Learning Early About Peanut Allergy (LEAP) Studies.Michelle L Sever, Agustin Calatroni, Graham Roberts, George du Toit, Henry T Bahnson, Suzana Radulovic, David Larson, Margie Byron, Alexandra F Santos, Michelle F Huff...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Jul 1
- Join now to see all
Press Mentions
Treating Peanut Allergies Early Could Make Kids Less Sensitive, Study FindsJanuary 24th, 2022- Peanut Allergy Treatment Effective on Toddlers, Study FindsJanuary 21st, 2022
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-Facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic IndividualsApril 24th, 2020- Join now to see all
Grant Support
- Investigation Into The Pathogenesis Of Chronic SinusitisNational Institute Of Allergy And Infectious Diseases1996–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
